Teva-Risedronate 35 mg (Risedronate Sodium (Risedronate Sodium Monohydrate) TABLET) 35 MG

Teva-Risedronate 35 mg tablets are a medication used to treat osteoporosis and improve bone density. This oral tablet helps maintain bone health and reduce fracture risk.

Strength

35 MG

Pack Size

4/30

Manufacturer / TM Owner

TEVA CANADA LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Risedronate sodium is primarily used to treat osteoporosis in postmenopausal women and men. It works by slowing bone loss and increasing bone density, which can help prevent fractures. This medication is also used to treat Paget's disease of bone, a condition that causes bones to break down and regrow abnormally.

Side Effects

Common effects of risedronate sodium may include stomach upset, heartburn, and muscle pain. Some users may experience headaches or dizziness. Severe side effects are rare but can include jawbone problems or unusual thigh bone fractures.

Precautions & Warnings

Risedronate sodium should be taken with a full glass of water while standing or sitting upright. It is important to avoid lying down for at least 30 minutes after taking this medication to prevent irritation. Do not take risedronate if you have low calcium levels or severe kidney disease.

Avoid Interactions

Risedronate sodium may interact with certain foods, supplements, and other medications. It is important to avoid taking calcium, magnesium, or iron supplements within two hours of taking risedronate. Always consult a healthcare provider before starting any new medication.

Frequently Asked Questions

Risedronate sodium is used to treat osteoporosis and Paget's disease of bone by slowing bone loss and increasing bone density.

Take risedronate sodium tablets with a full glass of water while standing or sitting upright, and avoid lying down for at least 30 minutes afterward.

Common side effects may include stomach upset, heartburn, muscle pain, headaches, and dizziness.

Risedronate sodium may interact with certain medications, so it is important to consult a healthcare provider before combining it with other treatments.

Risedronate sodium is not suitable for individuals with low calcium levels or severe kidney disease. Always consult a healthcare provider before starting this medication.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.